Clinical Characteristics and Treatment Outcomes of HIV+ and HIV- Tuberculosis Patients Followed and Treated at the Regional Hospital of Oyem, Northern Gabon: A Two-Year Retrospective Study
Microbiology Research Journal International, Volume 32, Issue 8,
Page 1-6
DOI:
10.9734/mrji/2022/v32i81335
Abstract
Background: The objective of this study was to analyse the clinical characteristics of HIV+ and HIV- tuberculosis patients followed and treated at the Oyem Regional Hospital Centre (ORHC).
Materials and Methods: During this study conducted between January 2019 and December 2021, data collection was based on the exploitation of medical records and registers of results from the medical analysis laboratory of the regional hospital of Oyem, in which there were personal data (gender and age) of the patients, the status of HIV infection, clinical characteristics (pulmonary or extra pulmonary TB), and finally, the therapeutic outcomes of the patients after anti-tuberculosis and antiretroviral treatment. Binomial test following the Normal distribution was used to find an association between the percentages of extrapulmonary TB and TB+/HIV+ co-infection.
Results: In this study, 128 confirmed TB cases were selected. While 54 (42.19%) were co-infected with TB+/HIV+, 74 patients (57.81%) were monoinfected with TB+/HIV+. Among all these patients, 93 (72.66%) were reported to have extra pulmonary TB and 35 (27.34%) had pulmonary TB. A normal binomial test showed that TB+/HIV+ co-infection was significantly associated with extrapulmonary TB (p=0.04). Patients were put on anti-tuberculosis treatment according to the manufacturers' indications. Despite a total of 15 deaths (8.93%) in both mono- and co-infected patients, there was a favourable outcome, with 35 patients (27.34%) declared cured. With 8 deaths, mortality was higher in the co-infected than in the non-HIV infected TB patients who recorded 7 deaths.
Conclusion: By indicating a relatively high prevalence of HIV infection in TB patients, this study showed that TB+/HIV+ co-infection was associated with extra pulmonary TB, the severe form of the disease, and increased mortality in patients, hence the need to strengthen joint activities to control this co-infection.
- Infection
- co-infection
- TB
- HIV
- Oyem
- Northern Gabon
How to Cite
References
World Health Organization: Tuberculosis deaths are on the rise for the first time in more than a decade due to the COVID-19 pandemic. Press release Geneva; 2021.
Zaheen A, Bloom BR. Tuberculosis in 2020 - new approaches to a continuing global health crisis. N Engl J Med. 2020;382(14):e26.
DOI: 10.1056/NEJMp2000325
PMID: 32242354
World Health Organization Tuberculosis/ HIV co-infection.
(Access on 28 October 2022).
World Heath Organization, Atlas; Tuberculosis; 2018.
(Access on 28 October 2022).
Medias 241 HIV/AIDS: 51,000 People Infected in Gabon; 2020.
(Access on 28 October 2022)
Guide to monitoring and evaluation of collaborative TB/HIV activities, Revision 2015 WHO. Google Scholar.
(Access on 28 October 2022).
Kettani AE, Jebbar S, Takourt B, et al. HIV co-infection in patients followed up for tuberculosis in the Division of infectious diseases at the Ibn Rochd University Hospital in Casablanca [HIV co-infection in patients followed up for tuberculosis in the division of infectious diseases at the Ibn Rochd University Hospital in Casablanca]. Pan Afr Med J. 2018;30:276.
Published 2018 Aug 16.
DOI: 10.11604/pamj.2018.30.276.13913
Castro Castrighini C, Reis RK, Souza Neves LA, Galvão MTG, Gir E. Epidemiological profile of HIV/tuberculosis co-infection in a City in the state of São Paulo, Brazil. J Antivir Antiretrovir. 2013; 5(5):119-122.
Noubom M, Nembot FD, Donfack H, Mfin PSK, Tchasse F. Characteristics of tuberculosis patients in Western Cameroon: 2000-2009. Pan Afr Med J. 2013;16:39. PubMed | Google Scholar
El Kamel A, Joobeur S, Skhiri N, Cheikh Mhamed S, Mribah H, Rouatbi N. The fight against tuberculosis in the world. Rev Pneumol Clin. 2015;71(2-3):181-187
Lee CM, Lee E, Bang JH, et al. Prevalence of multidrug-resistant tuberculosis in HIV/tuberculosis Co-infected patients. Infect Chemother. 2021;53(4):792-795. DOI: 10.3947/ic.2021.0085
Lima MM, Belluomini M, Almeida MM, Arantes GR. [HIV/tuberculosis co-infection: A request for a better surveillance]. Rev Saude Publica. 1997;31:217-20.
Adjoh K, Tchaptchet Heunda S, Patassi AA Sadzo Hetsu D, Awokou F, Tidjani O. Prevalence of HIV-TB co-infection and impact of HIV infection on pulmonary tuberculosis outcome in Togo A.Y. Dagnra. Bull. Soc. Pathol. Exot. 2011;104:342-346
DOI 10.1007/s13149-010-0079-3
Thiery Ndong Mba, Cedric Sima Obiang, Patrick Mickala, et al. Epidemiological and clinical profile of HIVTB co-infected patients in two departments of the Ngounié province in Southern Gabon. International Journal of Innovation Scientific Research and Review. 2021; 03(07):1489-1493.
Available:http://www.journalijisr.com
UNIES, N. and C.E.E. SOCIAL, The female dimension of HIV/AIDS in Africa; 2004.
(Access on 28 October 2022).
Guide to the management of TB/HIV coinfection of the National Tuberculosis Control Program of the Republic of Congo; 2020.
Dye C, Watt CJ, Bleed DM, et al. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA. 2005;293(22):2767–75.
Fujiwara PI, Clevenbergh P, Dlodlo RA. Management of adults living with HIV/AIDS in low-income, high-burden settings, with special reference to persons with tuberculosis. Int J Tuberc Lung Dis. 2005;9:946–58. [Medline]
Rakotonirina, El-C. Julio, et al. "Factors associated with the abandonment of anti-tuberculosis treatment in the city of Antananarivo, Madagascar", Santé Publique. 2009;21( 2):139-146.
Matos ED, Lemos AC, Bittencourt C, Mesquita CI, Kuhn P. Prevalence of HIV infection in patients hospitalized for tuberculosis in Bahia, Brazil. Braz J Infect Dis. 2007;11:208-11.
-
Abstract View: 214 times
PDF Download: 69 times
